Synlett 2011(10): 1407-1412  
DOI: 10.1055/s-0030-1260568
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

A Regioselective and High-Yielding Method for Formaldehyde Inclusion in the 3CC Groebke-Blackburn-Bienaymé Reaction: One-Step Access to 3-Aminoimidazoazines

Anuj Sharma, Hong-yu Li*
College of Pharmacy, Department of Pharmacoloy/Toxicology, The University of Arizona, Tucson, AZ 85721, USA
Fax: +1(520)6260794; e-Mail: hongyuli@pharmacy.arizona.edu;
Further Information

Publication History

Received 27 January 2011
Publication Date:
16 May 2011 (online)

Abstract

A regioselective, mild, convenient, and effective condition is developed for the inclusion of glyoxylic acid as formaldehyde equivalent in the 3CC reaction towards synthesis of 3-aminoalkyl imidazo-azines. In general, formaldehydes do not perform well with Ugi-type multicomponent sequences, and the method reported here is a regioselective and high-yielding one for the HCHO variant of Groebke-Blackburn-Bienaymé reaction.

    References and Notes

  • 1a Groebke K. Weber L. Mehlin F. Synlett  1998,  661 
  • 1b Bienaymé H. Bouzid K. Angew. Chem. Int. Ed.  1998,  37:  2234 
  • 1c Blackburn C. Guan B. Fleming P. Shiosaki K. Tsai S. Tetrahedron Lett.  1998,  39:  3635 
  • 2a Varma RS. Kumar D. Tetrahedron Lett.  1999,  40:  7665 
  • 2b Chen JJ. Golebiowski A. McClenaghan J. Klopfenstein SR. West L. Tetrahedron Lett.  2001,  42:  2269 
  • 2c Lu Y. Zhang W. QSAR Comb. Sci.  2004,  23:  827 
  • 2d Gudmundsson KS. Masquelin T. Perun T. Hulme C. Tetrahedron Lett.  2005,  46:  8355 
  • 2e Mironov MA. Tokareva MI. Ivantsova MN. Mokruskin VS. Russ. Chem. Bull. Int. Ed.  2006,  55:  1835 
  • 2f Parchinsky VZ. Schuvalova O. Ushalova O. Krachenko DV. Krasavin M. Tetrahedron Lett.  2006,  47:  947 
  • 2g Masquelin T. Baui H. Brickley B. Stephenson G. Schwerkoske J. Hulme C. Tetrahedron Lett.  2006,  47:  2989 
  • 2h Che C. Xiang J. Wang G.-X. Fathi R. Quan J.-M. Yang Z. J. Comb. Chem.  2007,  9:  982 
  • 2i Shaabani A. Soleeimani E. Maleki A. Monatsh. Chem.  2007,  138:  73 
  • 2j DiMauro EF. Kennedy JM. J. Org. Chem.  2007,  72:  1013 
  • 2k Nenadjenko VG. Reznichenko AL. Balenkova ES. Russ. Chem. Bull. Int. Ed.  2007,  56:  560 
  • 2l Umkehrer M. Ross G. Jager N. Burdack C. Kolb J. Hu H. Alvim-Gaston M. Hulme C. Tetrahedron Lett.  2007,  48:  2213 
  • 2m Rousseau AL. Matlaba P. Parkinson CJ. Tetrahedron Lett.  2007,  48:  4079 
  • 2n Adib M. Madhavi M. Noghani MA. Mirzaei P. Tetrahedron Lett.  2007,  48:  7263 
  • 2o Guchhait SK. Madaan C. Synlett  2009,  628 
  • 3a Sablayrolles C. Cros GH. Milhavet JC. Rechenq E. Chapat J.-P. Boucard M. Serrano JJ. McNeill JH. J. Med. Chem.  1984,  27:  206 
  • 3b Kaminski JJ. Bristol JA. Puchalski C. Lovey RG. Elliott AJ. Guzik H. Solomon DM. Conn DJ. Domalski MS. Wong SC. Gold EH. Long JF. Chiu PJS. Steinberg M. Mc Phail AT. J. Med. Chem.  1985,  28:  876 
  • 3c Clements-Jewery S. Danswan G. Gardner CR. Matharu SS. Murdoch R. Tully WR. Westwood R. J. Med. Chem.  1988,  31:  1220 
  • 3d Kaminski JJ. Wallmark B. Briving C. Andersson B.-M. J. Med. Chem.  1991,  34:  533 
  • 3e Rival Y. Grassy G. Michel G. Chem. Pharm. Bull.  1992,  40:  1170 
  • 3f Meurer L. Tolman RL. Chapin EW. Saperstein R. Vicario PP. Zrada M. MacCoss MM. J. Med. Chem.  1992,  35:  3845 
  • 3g Lober S. Hubner H. Gmeiner P. Bioorg. Med. Chem. Lett.  1999,  9:  97 
  • 3h Lhassani M. Chavignon O. Chezal J.-M. Teulade J.-C. Chapat J.-P. Snoeck R. Andrei G. Balzarini J. De Clerque E. Gueiffier A. Eur. J. Med. Chem.  1999,  271 
  • 3i Hamdouchi C. de Blas J. del Prado M. Gruber J. Heinz BA. Vance L. J. Med. Chem.  1999,  42:  50 
  • 3j Trapini G. Franco M. Latrofa A. Ricciardi L. Carotti A. Serra M. Sanna E. Biggio G. Liso G. J. Med. Chem.  1999,  42:  3934 
  • 3k Warshakoon NC. Wu S. Boyer A. Kawamoto R. Sheville J. Renock S. Xu K. Pokross M. Evdokimov AG. Walter R. Mekel M. Bioorg. Med. Chem. Lett.  2006,  16:  5598 
  • 4a Georges G. Vercauteren DP. Vanderveken DJ. Horion R. Evrard GH. Durant FV. George P. Wick AE. Eur. J. Med. Chem.  1993,  323 
  • 4b Jain AK. J. Med. Chem.  2004,  47:  947 
  • 4c Swainston Harrison T. Keating GM. CNS Drugs  2005,  19:  65 
  • 4d Wiegand MH. Drugs  2008,  68:  2411 
  • 4e Hanson SM. Morlock EV. Satyshur KA. Czajkowski C. J. Med. Chem.  2008,  51:  7243 
  • 4f Chernyak N. Gevorgyan V. Angew. Chem. Int. Ed.  2010,  49:  2743 
  • 5 Li HY. McMillen T. Heap CR. McCann DJ. Yan L. Campbell RM. Mundla SR. King CR. Dierks EA. Anderson BD. Britt KS. Huss KL. Voss MD. Wang Y. Clawson DK. Yingling JM. Sawyer JS.
    J. Med. Chem.  2008,  51:  2302 
  • 6a Wu Z. Fraley ME. Bilodeau MT. Kaufman ML. Tasber ES. Balitza AE. Hartman GD. Coll KE. Rickert K. Shipman J. Shi B. Sepp-Lerenzino L. Thomas KA. Bioorg. Med. Chem.  2004,  14:  909 
  • 6b Breitenbucher GJ. Tichenor MS. Merit JE. Hawryluk NA. Chambers AL. Keith JM.   , 
  • 7a Hulme C. Gore V. Curr. Med. Chem.  2003,  10:  51 
  • 7b Hulme C. Nixey T. Curr. Opin. Drug Discovery Dev.  2003,  6:  921 
  • 7c Dömling A. Chem. Rev.  2006,  106:  17 
  • 7d Rivera DG. Pando O. Coll F. Tetrahedron  2006,  62:  8327 
  • 7e Rivera DG. Wessjohann LA. Molecules  2007,  12:  1890 
  • 7f Banfi L. Basso A. Cerulli V. Guanti G. Riva R. J. Org. Chem.  2008,  73:  1608 
  • 7g Hulme C. Lee Y.-S. Mol. Diversity  2008,  12:  1 
  • 7h Banfi L. Riva R. Basso A. Synlett  2010,  23 
  • 7i Nichol GS. Sharma A. Li H.-Y. Acta Crystallogr.  2011,  E67:  o833 
  • 8a Sisko J. Kassik AJ. Mellinger M. Filan JJ. Allen A. Olsen MA. J. Org. Chem.  2000,  65:  1516 
  • 8b Lyon MA. Kercher TS. Org. Lett.  2004,  6:  4989 
  • 9a Kaminski JJ. Hilbert JM. Pramanik BN. Solomon DM. Conn DJ. Rizvi RK. Elliott AJ. Guzik H. Lovey RG. Domalski MS. Wong S.-C. Puchalski C. Gold EH. Long JF. Chiu PJS. McPhailt AT. J. Med. Chem.  1987,  30:  2031 
  • 9b Groziak MP. Wilson SR. Clauson GL. Leonard NJ. J. Am. Chem. Soc.  1986,  108:  8002 
  • 9c Katritzky AR. Xu Y.-J. Tu H. J. Org. Chem.  2003,  68:  4935 
  • 12 Mandair GS. Light M. Russell A. Hursthouse M. Bradley M. Tetrahedron Lett.  2002,  43:  4267 
10

Representative Procedure for the Synthesis of N -(2,6-dimethylphenyl)imidazo[1,2- a ]pyridin-3-amine (3b, Table 2)
To a solution of 2-aminopyridine (1b, 1.05 mmol) in MeOH (1.5 mL), was added glyoxylic acid (1.78 mmol) followed by HClO4 (0.105 mmol), and the solution was stirred for 10 min. 2-Isocyano-1,3-dimethylbenzene (1.05 mmol) was added to this mixture, and the solution was stirred for 12 h. MeOH was evaporated from the reaction mixture, and the crude was purified through silica gel chromatography to provide 3b in 77% yield. ¹H NMR (400 MHz, DMSO-d 6):
δ = 8.72 (d, J = 8 Hz, 1 H), 7.81 (d, J = 4 Hz, 2 H), 7.60 (s, 1 H), 7.52-7.48 (m, 1 H), 7.11 (d, J = 8 Hz, 2 H), 7.05-7.02 (m, 3 H), 2.09 (s, 6 H). ¹³C NMR (400 MHz, DMSO-d 6):
δ = 138.5, 136.4, 135.8, 133.4, 132.0, 131.7, 129.3, 128.0, 125.8, 125.3, 116.6, 112.9, 106.3, 18.1. HRMS: m/z calcd for C15H16N3: 238.13387; found: 238.13377. LC-MS (ES): 98.6% (λ = 214 nm).

11

Formation of regioisomer was observed during optimization studies using paraformaldehyde as formaldehyde source (entry 8, Table  [¹] ).

13

Nichol, G. S.; Sharma, A.; Li, H. Y. unpublished results.